MELPHALAN Ideogen subst sèche 50 mg c solv flac
7680681960010
CH-68196
L01AA03
07.16.1.
Reimbursement limitations:
ALKERAN1
Pris en charge uniquement dans le myélome multiple et à doses élevées en traitement préalable …
1 / 2
google
Details
- Product number
- 6819601
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Pulver: melphalanum 50 mg ut melphalani hydrochloridum, povidonum, acidum hydrochloridum, pro vitro. Solvens: natrii citras dihydricus corresp. natrium 53.4 mg, propylenglycolum 6214.8 mg, ethanolum 96 per centum 424.3 mg, aqua ad iniectabile q.s. ad solutionem pro 10 ml.
Articles (1)
Melphalan Ideogen 50 mg, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLV
|
- | Substance | HNIDK |
|
PUL
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
SOLV
|
53.4 MG | Substance | HBESI |
|
PUL
|
- | Substance | WIZUS |
|
PUL
|
- | Substance | HNIDK |
|
SOLV
|
6214.8 MG | Substance | HBESI |
|
SOLV
|
424.3 MG | Substance | HBESI |
|
PUL
|
- | Substance | HNIDK |
|
SOLV
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 79.50
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/04/2025
Authorization holder
IDEOGEN AG
8807 Freienbach
Authorization information
- Swissmedic authorization number
- 68196
- Drug name
- Melphalan Ideogen, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
- Galenic form
- PULMK
- ATC Code
- L01AA03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 26/08/2021
- Authorization expiration date
- 25/08/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MELPHALAN Ideogen subst sèche 50 mg c solv flac
- Description (DE)
- MELPHALAN Ideogen Trockensub 50 mg c Solv Durchstf
- Market launch
- 26/08/2021
- Narcotic (BTM)
- No